SCHEMBL44348

SCHEMBL44348

NC(O)CP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263539 0.78 GABBR2 (0.50)
SCHEMBL5355272 0.78
SCHEMBL562383 0.75 ANPEP (0.60)
SCHEMBL27996625 0.75 GABBR2 (0.42)
SCHEMBL31372811 0.73
SCHEMBL366378 0.73
SCHEMBL8141042 0.73
SCHEMBL10723684 0.73
SCHEMBL6364333 0.73
SCHEMBL27649058 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8948 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104570-A1 LIPOSOMAL SUSPENSION AND SYSTEM AND METHOD OF PERITONEAL ADMINISTRATION OF LIPOSOMAL SUSPENSION GENFIT (FR) 2026-05-21 WO claimed
US-20260130982-A1 METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES UNIV NORTHWESTERN (US) 2026-05-14 US claimed
US-12611447-B2 Methods for treating bone mineralization disorders ALEXION PHARMACEUTICALS, INC. (US) 2026-04-28 US claimed
EP-3875606-B1 LIPOSOMAL PREPARATIONS FOR NON-INVASIVE-PRENATAL OR CANCER SCREENING LGC CLINICAL DIAGNOSTICS INC (US) 2026-03-25 EP claimed
EP-4712948-A2 GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME Renagade Therapeutics Management Inc. (US) 2026-03-25 EP claimed
US-12569437-B2 Disease-site-specific liposomal formulation OSAKA UNIVERSITY (JP) 2026-03-10 US claimed
EP-4695602-A1 METHODS OF DETECTING OVER-IMMUNOSUPPRESSION AND UNDER- IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS Olaris, Inc. (US) 2026-02-18 EP claimed
US-12553071-B2 Genetically engineered strains with reduced byproduct formation DSM IP ASSETS B.V. (DK) 2026-02-17 US claimed
US-20260041785-A1 POLYGLYCEROL-CONJUGATED LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME GENERATION BIO CO (US) 2026-02-12 US claimed
EP-4689180-A1 MODULATION OF TARGET MOLECULE-LIPID BILAYER INTERACTIONS F. Hoffmann-La Roche AG (CH) 2026-02-11 EP claimed
WO-1990003430-A1 CELL CULTURE MEDIUM FOR ENHANCED CELL GROWTH, CULTURE LONGEVITY AND PRODUCT EXPRESSION CETUS CORPORATION (US) 1990-04-05 WO claimed
EP-0359473-A2 A method of determining the amount of the substances or ions contained in an ionic solution or a non-deionized solution and a crystal oscillator used therefor SOGO PHARMACEUTICAL COMPANY LIMITED (JP) 1990-03-21 EP claimed
EP-0363400-A4 METHOD AND APPARATUS FOR PREPARING COMPOSITE SKIN REPLACEMENT. UNIV CALIFORNIA (US) 1990-03-16 EP claimed
US-4886786-A PROTECTION FOR EYES DURING OR AFTER SURGERY LINDSTROM RICHARD L (US) 1989-12-12 US claimed
WO-1988009171-A1 PHOSPHOETHANOLAMINE FOR TREATMENT OF ALZHEIMER'S DISEASE BAYLOR COLLEGE OF MEDICINE (US) 1988-12-01 WO claimed
WO-1988008305-A1 METHOD AND APPARATUS FOR PREPARING COMPOSITE SKIN REPLACEMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1988-11-03 WO claimed
EP-0249557-A1 Culture medium containing human albumin, method of preparing an injectable product from this medium, product obtained and its use, composition obtained FONDATION CENTRE NATIONAL DE TRANSFUSION SANGUINE (FR) 1987-12-16 EP claimed
US-4673649-A CULTURE PRODUCT OF NUTRIENTS, SKIN GROWTH FACTOR AND INSULIN UNIVERSITY PATENTS, INC. (US) 1987-06-16 US claimed
US-4316882-A SKIN TESTING USING N-PENCILLOYL AMINES LEVINE BERNARD B 1982-02-23 US claimed
US-4228147-A A PENICYLOYLAMINE, BENZYLPENICILLIN, SODIUM BENZYLPENICILLOATE, AND A SOLVENT LEVINE BERNARD B 1980-10-14 US claimed